1492 Capital Management LLC

Position in CRL — Charles River Laboratories International, Inc.

CIK 1584087 MILWAUKEE, WI

Position in CRL

as of Mar 31, 2026 · filed Apr 22, 2026 Compact

Position Value

$1,358,437

+$149,788 QoQ

Shares Held

7,875

+30.0% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.53%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

1492 Capital Management LLC holds $5,477,639 across 3 Diagnostics & Research names. CRL ranks #2 (24.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ADPT	Adaptive Biotechnologies Corp	281,096	$3,901,612
2	CRL	Charles River Laboratories International, Inc. This page	7,875	$1,358,437
3	CDNA	CareDx, Inc.	12,534	$217,590

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,358,437	7,875	+30.0%	Shares	Sole	2026-04-22
2025-12-31	$1,208,649	6,059	+5.6%	Shares	Sole	2026-02-10
2022-06-30	$1,227,759	5,738	+0.2%	Shares	Sole	2022-08-10
2022-03-31	$1,626,580	5,728	-1.2%	Shares	Sole	2022-05-12
2021-12-31	$2,184,193	5,797	0.0%	Shares	Sole	2022-02-14
2021-09-30	$2,392,247	5,797	-1.3%	Shares	Sole	2021-11-12
2021-06-30	$2,173,280	5,875	0.0%	Shares	Sole	2021-08-13
2021-03-31	$1,702,751	5,875	-2.5%	Shares	Sole	2021-08-13
2020-12-31	$1,506,156	6,028	+8.5%	Shares	Sole	2021-02-12
2020-09-30	$1,257,929	5,555	+6.3%	Shares	Sole	2020-11-13
2020-06-30	$911,153	5,226	-0.7%	Shares	Sole	2020-08-13
2020-03-31	$663,990	5,261	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.